ClearPoint Neuro Inc (NASDAQ:CLPT) price on Thursday, February 27, fall -17.51% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.20.
A look at the stock’s price movement, the close in the last trading session was $17.22. Turning to its 52-week performance, $19.22 and $5.11 were the 52-week high and 52-week low respectively. Overall, CLPT moved -20.82% over the past month.
ClearPoint Neuro Inc’s market cap currently stands at around $391.84 million, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 8.24M for the company’s revenue for the quarter, with a low and high estimate of 7.9M and 8.72M respectively. The average forecast suggests up to a 7.86% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 38.25M, representing a 21.84% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CLPT is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
CLPT’s current price about -19.32% and -14.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.18, while 7-day volatility ratio is 8.19% and 6.16% in the 30-day chart. Further, ClearPoint Neuro Inc (CLPT) has a beta value of 1.04, and an average true range (ATR) of 1.17. Analysts have given the company’s stock an average 52-week price target of $30, forecast between a low of $30 and high of $30. Looking at the price targets, the low is -111.27% off current price level while to achieve the yearly target high, price needs to move -111.27%. Nonetheless, investors will most likely welcome a -111.27% jump to $30 which is the analysts’ median price.
If we refocus on ClearPoint Neuro Inc (NASDAQ:CLPT), historical trading data shows that trading volumes averaged 217.64K over the past 3 months. The company’s latest data on shares outstanding shows there are 27.62 million shares.
The 13.38% of ClearPoint Neuro Inc’s shares are in the hands of company insiders while institutional holders own 27.99% of the company’s shares. Current price change has pushed the stock -7.64% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLPT stock continues to rise going into the next quarter.
